The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment

Scientific Reports

Volumn 5, Issue , 2015, Pages 8421-

  Li, Hongde ^a,f   Zhu, Wandi ^b,f   Zhang, Leike ^c   Lei, Hehua ^a   Wu, Xiangyu ^a,f   Guo, Lin ^c   Chen, Xinwen ^b   Wang, Yulan ^a,e   Tang, Huiru ^a,d  

^a Wuhan National Laboratory for Optoelectronics   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

^c WUHAN UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

^e ZHEJIANG UNIVERSITY   (China)

^f UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEXOSAMINE; PHOSPHATIDYLCHOLINE;

BIOSYNTHESIS; CITRIC ACID CYCLE; EXTRACELLULAR SPACE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMAN; INTRACELLULAR SPACE; METABOLISM; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY; VIRUS REPLICATION;

BIOSYNTHETIC PATHWAYS; CELL LINE, TUMOR; CITRIC ACID CYCLE; EXTRACELLULAR SPACE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEXOSAMINES; HUMANS; INTRACELLULAR SPACE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; METABOLOMICS; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; VIRUS REPLICATION;

EID: 84923009315     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08421     Document Type: Article

References (60)

1. Lavanchy, D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11, 97-107 (2004).
2. Ganem, D. & Prince, A. M. Mechanisms of disease: Hepatitis B virus infection -Natural history and clinical consequences. N Engl J Med 350, 1118-1129 (2004).
3. Lai, C. L. et al. Viral hepatitis B. Lancet 362, 2089-2094 (2003).
4. Tong, A. P. et al. Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model. Proteomics 8, 2012-2023 (2008).
5. Hajjou, M. et al. cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV. J Med Virol 77, 57-65 (2005).
6. Yang, F. et al . Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver. J Hepatol 48, 12-19 (2008).
7. Kim, K. H. et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARyγ. Gastroenterology 132, 1955-1967 (2007).
8. Li, H. D. et al . Enhanced green fluorescent protein transgenic expression in vivo is not biologically inert. J Proteome Res 12, 3801-3808 (2013).
9. Claus, S. P. et al. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol 4, 219 (2008).
10. Sells, M. A. et al. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84, 1005-1009 (1987).
11. Wang, J. H. et al. Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2. Proteomics 9, 1672-1682 (2009).
12. Williamson, J. R. & Cooper, R. H. Regulation of the citric acid cycle inmammalian systems. FEBS Lett 117, K73-K85 (1980).
13. 3] serine allows in vivo kinetic measurement of serine turnover, homocysteine remethylation, and transsulfuration processes in human one-carbon metabolism. Am J Clin Nutr 72, 1535-1541 (2000).
14. Kornfeld, R. Studies on L-glutamine D-fructose 6-phosphate aminotransferase. J Biol Chem 242, 3135-3141 (1967).
15. Sasai, K. et al. UDP-GlcNAc concentration is an important factor in the biosynthesis of beta 1,6-branched oligosaccharides: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V. Glycobiology12, 119-127 (2002).
16. Esko, J. D. et al. Animal cells dependent on exogenous phosphatidylcholine for membrane biogenesis. Proc Natl Acad Sci USA 79, 1698-1702 (1982).
17. Yalcin, A. et al. Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling. Oncogene 29, 139-149 (2010).
18. Roberts, S. J. et al. Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities. Biochem J 382, 59-65 (2004).
19. Kent, C. CTP:phosphocholine cytidylyltransferase. Biochim Biophys Acta 1348, 79-90 (1997).
20. Fisgin, N. T. et al. Oxidative stress and antioxidant defense in patients with chronic hepatitis B. Clin Lab 58, 273-280 (2012).
21. Bunton, C. A. Oxidation of aα-diketones and a-keto-acids by hydrogen peroxide. Nature 163, 444-444 (1949).
22. Andrae, U. et al. Pyruvate and related aα-ketoacids protect mammalian cells in culture against hydrogen peroxide-induced cytotoxitcity. Toxicol Lett 28, 93-98 (1985).
23. Salahudeen,A.K. et al.Hydrogen peroxide-induced renal injury-Aprotective role for pyruvate in vitro and in vivo. J Clin Invest 88, 1886-1893 (1991).
24. Lau, K. S. et al. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129, 123-134 (2007).
25. Wellen, K. E. et al. The hexosamine biosynthetic pathway couples growth factorinduced glutamine uptake to glucose metabolism. Genes Dev 24, 2784-2799 (2010).
26. Comer, F. I. & Hart, G. W. O-glycosylation of nuclear and cytosolic proteins -Dynamic interplay between O-GlcNAc and O-phosphate. J Biol Chem 275, 29179-29182 (2000).
27. Robinson, K. A. et al. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 44, 1438-1446 (1995).
28. McClain, D. A. & Crook, E. D. Hexosamines and insulin resistance. Diabetes 45, 1003-1009 (1996).
29. Shaw, P. et al . Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 12, 921-930 (1996).
30. Chou, T. Y. et al. Glycosylation of the c-Myc transactivation domain. Proc Natl Acad Sci USA 92, 4417-4421 (1995).
31. Ahmad, W. et al. Serine 204 phosphorylation and O-b-GlcNAC interplay of IGFBP-6 as therapeutic indicator to regulate IGF-II functions in viral mediated hepatocellular carcinoma. Virol J 8, 208 (2011).
32. Weigert, C. et al. Overexpression of glutamine: fructose-6-phosphateamidotransferase induces transforming growth factor-b1 synthesis in NIH-3T3 fibroblasts. FEBS Lett 488, 95-99 (2001).
33. Burt, D. J. et al . P38 mitogen-activated protein kinase mediates hexosamineinduced TGF b1 mRNA expression in human mesangial cells. Diabetologia 46, 531-537 (2003).
34. de Molina, A. R. et al. Choline kinase is a novel oncogene that potentiates RhoAinduced carcinogenesis. Cancer Res 65, 5647-5653 (2005).
35. Hernando, E. et al. A critical role for choline kinase-α in the aggressiveness of bladder carcinomas. Oncogene 28, 2425-2435 (2009).
36. Hernandez-Alcoceba, R. et al. In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery. Cancer Res 59, 3112-3118 (1999).
37. Morrish, F. et al. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene 28, 2485-2491 (2009).
38. Glunde, K. et al. Hypoxia regulates choline kinase expression through hypoxiainducible factor-1 a signaling in a human prostate cancer model. Cancer Res 68, 172-180 (2008).
39. Glunde, K. et al. Choline metabolism in malignant transformation. Nat Rev Cancer 11, 835-848 (2011).
40. Ackerstaff, E. et al.Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 61, 3599-3603 (2001).
41. Bell, J. D. & Bhakoo, K. K. Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours. NMR Biomed 11, 354-359 (1998).
42. Hagen, T. M. et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 91, 12808-12812 (1994).
43. Chemin, I. & Zoulim, F. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett 286, 52-59 (2009).
44. Kuo, M. T. & Savaraj, N. Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers. Mol Carcinog 45, 701-709 (2006).
45. Kim, K. et al. Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXR alpha. Biochem J 416, 219-230 (2008).
46. Sage, A. T. et al. Hexosamine biosynthesis pathway flux promotes endoplasmic reticulum stress, lipid accumulation, and inflammatory gene expression in hepatic cells. Am J Physiol Endocrinol Metabol 298, E499-E511 (2010).
47. Slawson, C. et al. O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks. J Cell Biochem 97, 71-83 (2006).
48. Ito, K. et al. Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol 84, 12850-12861 (2010).
49. Shim, J.K. et al. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus. J Gastroenterol Hepatol 19, 1374-1387 (2004).
50. Block, T. M. et al. Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nat Med 4, 610-614 (1998).
51. Satoh, O. et al. Lipid composition of hepatitis B virus surface antigen particles and the particle-producing human hepatoma cell lines. J Lipid Res 31, 1293-1300 (1990).
52. Zhang, H. et al. Differential regulation of host genes including hepatic fatty acid synthase in HBV-transgenic mice. J Proteome Res 12, 2967-2979 (2013).
53. Xiao, C. et al. An optimized buffer system for NMR-based urinary metabonomics with effective pH control, chemical shift consistency and dilution minimization. Analyst 134, 916-925 (2009).
54. Eriksson, L. et al. CV-ANOVA for significance testing of PLS and OPLS (R) models. J Chemom 22, 594-600 (2008).
55. Jain, M. et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336, 1040-1044 (2012).
56. Zhang, L.-K. et al. Identification of host proteins involved in Japanese encephalitis virus infection by quantitative proteomics analysis. J Proteome Res 12, 2666-2678 (2013).
57. Shilov, I. V. et al. The paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6, 1638-1655 (2007).
58. Li, M.-D. et al. O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination. Cell Metab 17, 303-310 (2013).
59. Glunde, K. et al. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Cancer Res 65, 11034-11043 (2005).
60. Meng, Z. J. et al. Inhibition of hepatitis B virus gene expression and replication by endoribonuclease-prepared siRNA. J Virol Methods 150, 27-33 (2008).